Back to Journals » ClinicoEconomics and Outcomes Research » Volume 5

Review

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study

       
Total article views   HTML views PDF downloads Totals
14,443 Dovepress* 11,644+ 2,618 14,262
PubMed Central* 2,799 1,045 3,844
Totals 14,443 3,663 18,106
*Since 11 April 2013
+Since July 2016

View citations on PubMed Central and Google Scholar